The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...

Pharmaceutical company Bayer took over weed killer Roundup in its acquisition of US agrochemical company Monsanto back in ...

Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business ...

Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy: Our Bureau, Bengaluru Wednesday, April 2, 2025, 14:50 Hrs [IST] Bayer Ph ...

Bayer Hit With $2 Billion Roundup Verdict in US State of Georgia Cancer Case ... set aside $5.9 billion in legal provisions. The German pharmaceutical and biotechnology group acquired Roundup ...

European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

Bayer says it disagrees with the verdict and plans to appeal. But the German pharmaceutical and biotechnology group faces ...

German agricultural and pharmaceutical giant Bayer has been instructed by a state court in the US state of Georgia to shell out $2.1 billion (€1.9bn) in a case regarding its Roundup weed killer ...

BERLIN (Reuters) -Bayer was ordered by a jury in the U.S ... group has set aside $5.9 billion in legal provisions. The German pharmaceutical and biotechnology group acquired Roundup as part ...